810132C

18:1-06:0 NBD PC

Avanti Research^™ - A Croda Brand 810132C

• 別名: 1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
• 実験式（ヒル表記法）: C₃₈H₆₄N₅O₁₁P
• CAS番号: 106974-05-4
• 分子量: 797.92
• MDL番号: MFCD00036835
• UNSPSCコード: 12352211
• NACRES: NA.25

特性

• アッセイ: >99% (TLC)
• フォーム: liquid
• 包装: pkg of 1 × 1 mL (810132C-1mg)
• メーカー／製品名: Avanti Research^™ - A Croda Brand 810132C
• 濃度: 1 mg/mL (810132C-1mg)
• 輸送温度: dry ice
• 保管温度: −20°C

詳細

詳細

Phosphocholine is considered as a precursor molecule. It is formed during the breakdown of phosphatidylcholine (PC) metabolism. 18:1-06:0 NBD PC is a fluorescent lipid analog/probe.

アプリケーション

18:1-06:0 NBD PC is suitable for use:

• as a component in preparing lipid solution for bilayer formation
• to use as a single donor in fluorescence resonance energy transfer (FRET) based assay
• to prepare phospholipid-coated beads

生物化学的／生理学的作用

NBD‐PC can be used to probe the existence of (Rho‐labeled) protease‐activated receptor (PAR) pepducins in the outer and inner leaflets.

包装

5 mL Amber Glass Screw Cap Vial (810132C-1mg)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• ピクトグラム: GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H302,H315,H319,H331,H336,H351,H361d,H372
• 注意書き: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• 危険有害性の分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• ターゲットの組織: Central nervous system
• WGK: WGK 3